These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11766420)

  • 21. High blood cholesterol.
    National Heart, Lung and Blood Institute
    Nutr Clin Care; 2003; 6(3):108-14. PubMed ID: 14979453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The heart of the matter. National guidelines urge more aggressive cholesterol treatment.
    Leake NB
    Adv Nurse Pract; 2002 Jan; 10(1):42-7; quiz 48-9. PubMed ID: 12420511
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004.
    Ghandehari H; Kamal-Bahl S; Wong ND
    Am Heart J; 2008 Jul; 156(1):112-9. PubMed ID: 18585505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do disease management programs for patients with coronary heart disease make a difference? Experiences of nine practices.
    Walsh MN; Simpson RJ; Wan GJ; Weiss TW; Alexander CM; Markson LE; Berger ML; Pearson TA
    Am J Manag Care; 2002 Nov; 8(11):937-46. PubMed ID: 12437309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult treatment panel III and the management of dyslipidemia risk factors.
    Stein EA
    Postgrad Med; 2002 Oct; 112(4 Suppl):12-7. PubMed ID: 19667595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LDL-apheresis: indications and clinical experience in a tertiary cardiac centre.
    Archontakis S; Pottle A; Hakim N; Ilsley C; Barbir M
    Int J Clin Pract; 2007 Nov; 61(11):1834-42. PubMed ID: 17935547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lipid profile in 4 minutes. Impressing your coronary heart disease patients].
    Janssen K
    MMW Fortschr Med; 2000 Jul; 142(26-27):39. PubMed ID: 10929482
    [No Abstract]   [Full Text] [Related]  

  • 28. [Fasting and nonfasting lipids--secondary publication].
    Langsted A; Freiberg JJ; Nordestgaard BG
    Ugeskr Laeger; 2009 Jun; 171(26):2184-7. PubMed ID: 19678434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [LDL target values in diabetic patients].
    Krone W
    Dtsch Med Wochenschr; 2006 Jun; 131(22):1288. PubMed ID: 16817249
    [No Abstract]   [Full Text] [Related]  

  • 30. Exploring the gap between National Cholesterol Education Program guidelines and clinical practice in secondary care: results of a cross-sectional study involving over 10 000 patients followed in different specialty settings across Italy.
    Rapezzi C; Biagini E; Bellis P; Cafiero M; Velussi M; Ceriello A; Cooke RM; Schweiger C;
    J Cardiovasc Med (Hagerstown); 2008 Sep; 9(9):878-87. PubMed ID: 18695423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines.
    Shai I; Rimm EB; Hankinson SE; Curhan G; Manson JE; Rifai N; Stampfer MJ; Ma J
    Circulation; 2004 Nov; 110(18):2824-30. PubMed ID: 15492318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002.
    Keevil JG; Cullen MW; Gangnon R; McBride PE; Stein JH
    Circulation; 2007 Mar; 115(11):1363-70. PubMed ID: 17353444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults.
    Hyre AD; Muntner P; Menke A; Raggi P; He J
    Ann Epidemiol; 2007 Jul; 17(7):548-55. PubMed ID: 17395483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lipid therapy in risk patients. Do we concentrate too much on LDL cholesterol?].
    März W
    MMW Fortschr Med; 2005 Apr; 147(14):14. PubMed ID: 15887675
    [No Abstract]   [Full Text] [Related]  

  • 35. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events.
    Koro CE; Bowlin SJ; Stump TE; Sprecher DL; Tierney WM
    Am Heart J; 2006 Mar; 151(3):755.e1-755.e6. PubMed ID: 16504648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practical steps for targeting heart disease's biggest villain.
    Clin Resour Manag; 2001 Dec; 2(12):190-1, 177. PubMed ID: 11794829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Introduction: Apolipoproteins and guidelines for prevention of cardiovascular disease.
    Faergeman O
    J Intern Med; 2006 May; 259(5):434-6. PubMed ID: 16629848
    [No Abstract]   [Full Text] [Related]  

  • 40. [Total cardiovascular risk. When is a medication prophylaxis meaningful].
    Einecke D
    MMW Fortschr Med; 2003 Oct; 145(44):6-8. PubMed ID: 14655495
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.